222 related articles for article (PubMed ID: 16504918)
21. [Use of high dose intravenous immunoglobulin in neurologic disease].
Korsak J; Zaleska B; Orłowska E; Kotowicz J
Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease.
Bounfour T; Bouaziz JD; Bézier M; Cordoliani F; Saussine A; Petit A; Juillard C; Bagot M; Rybojad M
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1150-7. PubMed ID: 23906502
[TBL] [Abstract][Full Text] [Related]
23. Modulation of complement-mediated immune damage by intravenous immune globulin.
Basta M
Clin Exp Immunol; 1996 May; 104 Suppl 1():21-5. PubMed ID: 8625538
[TBL] [Abstract][Full Text] [Related]
24. Improvement in dermatomyositis rash associated with the use of antiestrogen medication.
Sereda D; Werth VP
Arch Dermatol; 2006 Jan; 142(1):70-2. PubMed ID: 16415389
[TBL] [Abstract][Full Text] [Related]
25. Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis.
Elst EF; Klein M; de Jager W; Kamphuis S; Wedderburn LR; van der Zee R; Albani S; Kuis W; Prakken BJ
Arthritis Rheum; 2008 Feb; 58(2):547-55. PubMed ID: 18240224
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis.
Marie I; Hachulla E; Levesque H; Reumont G; Ducrotte P; Cailleux N; Hatron PY; Devulder B; Courtois H
J Rheumatol; 1999 Dec; 26(12):2706-9. PubMed ID: 10606390
[TBL] [Abstract][Full Text] [Related]
27. The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis.
Ogata A; Endo M; Aoi J; Takahashi O; Kadomatsu T; Miyata K; Tian Z; Jinnin M; Fukushima S; Ihn H; Oike Y
Biochem Biophys Res Commun; 2012 Feb; 418(3):494-9. PubMed ID: 22281496
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy.
Williams L; Chang PY; Park E; Gorson KC; Bayer-Zwirello L
Obstet Gynecol; 2007 Feb; 109(2 Pt2):561-3. PubMed ID: 17267895
[TBL] [Abstract][Full Text] [Related]
30. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins.
Tournadre A; Porcherot M; Chérin P; Marie I; Hachulla E; Miossec P
Cytokine; 2009 Jun; 46(3):297-301. PubMed ID: 19303320
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous lesions of dermatomyositis with supervening fibrosis.
Magro CM; Dyrsen M; Kerns MJ
J Cutan Pathol; 2008 Jan; 35(1):31-9. PubMed ID: 18095992
[TBL] [Abstract][Full Text] [Related]
32. Intravenous immunoglobulin therapy for neuromuscular disorders.
Ross MA
Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
[TBL] [Abstract][Full Text] [Related]
33. [Multifocal motor neuropathies with conduction block: long-term follow-up of ten patients treated with IVIg].
Cros D; Drake K
Rev Neurol (Paris); 2006 Jun; 162 Spec No 1():3S46-3S50. PubMed ID: 17075525
[TBL] [Abstract][Full Text] [Related]
34. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
Zinman L; Bril V
Ann N Y Acad Sci; 2008; 1132():264-70. PubMed ID: 18567877
[TBL] [Abstract][Full Text] [Related]
35. MHC Class I overexpression on muscles in early juvenile dermatomyositis.
Li CK; Varsani H; Holton JL; Gao B; Woo P; Wedderburn LR;
J Rheumatol; 2004 Mar; 31(3):605-9. PubMed ID: 14994413
[TBL] [Abstract][Full Text] [Related]
36. Immunopathogenesis of inflammatory myopathies.
Dalakas MC
Ann Neurol; 1995 May; 37 Suppl 1():S74-86. PubMed ID: 8968219
[TBL] [Abstract][Full Text] [Related]
37. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
Soelberg Sorensen P
Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
[TBL] [Abstract][Full Text] [Related]
38. The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study.
Kampylafka EI; Kosmidis ML; Panagiotakos DB; Dalakas M; Moutsopoulos HM; Tzioufas AG
Clin Exp Rheumatol; 2012; 30(3):397-401. PubMed ID: 22510247
[TBL] [Abstract][Full Text] [Related]
39. [Juvenile dermatomyositis: diagnosis and treatment].
Gissinger-Prévot S; Figarella-Branger D; Mancini J; Chabrol B
Arch Pediatr; 2008 Jan; 15(1):50-3. PubMed ID: 18164188
[TBL] [Abstract][Full Text] [Related]
40. Nicotinamide adenine dinucleotide tetrazolium reductase identifies microvasculature activation in muscle from adult patients with dermatomyositis.
Charles-Schoeman C; Verity MA
J Rheumatol; 2012 Jan; 39(1):94-9. PubMed ID: 22174214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
